Company Valuation: Moderna, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,518 41,340 102,976 69,006 37,919 12,545 12,545 -
Change - 534.2% 149.1% -32.99% -45.05% -66.92% 0% -
Enterprise Value (EV) 1 5,548 36,842 92,848 59,104 29,315 4,875 8,083 10,113
Change - 564.09% 152.02% -36.34% -50.4% -83.37% 65.82% 25.12%
P/E ratio -12.6x -53.3x 8.98x 8.93x -8.07x -3.57x -3.59x -4.6x
PBR 6.14x 16.3x 7.24x 3.7x 2.74x 1.21x 1.8x 3.01x
PEG - -2x -0x -0.3x 0x 0.1x 5.82x 0.2x
Capitalization / Revenue 108x 51.5x 5.58x 3.58x 5.54x 3.89x 5.69x 4.25x
EV / Revenue 92.1x 45.9x 5.03x 3.07x 4.28x 1.51x 3.67x 3.43x
EV / EBITDA -10.8x -50.3x 6.86x 6.05x -8.1x -1.39x -2.4x -3.92x
EV / EBIT -10.2x -48.3x 6.98x 6.27x -6.92x -1.27x -2.15x -3.43x
EV / FCF -11.3x 18.8x 6.96x 12.9x -7.66x -1.29x -2.34x -3.31x
FCF Yield -8.84% 5.32% 14.4% 7.75% -13% -77.2% -42.8% -30.2%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -1.55 -1.96 28.29 20.12 -12.33 -9.13 -9.073 -7.092
Distribution rate - - - - - - - -
Net sales 1 60.21 803.4 18,471 19,263 6,848 3,224 2,204 2,952
EBITDA 1 -514.7 -731.9 13,528 9,768 -3,618 -3,501 -3,367 -2,580
EBIT 1 -545.7 -763.1 13,296 9,420 -4,239 -3,832 -3,766 -2,950
Net income 1 -514 -747.1 12,202 8,362 -4,714 -3,503 -3,529 -2,742
Net Debt 1 -970.6 -4,498 -10,128 -9,902 -8,604 -7,671 -4,462 -2,432
Reference price 2 19.56 104.47 253.98 179.62 99.45 32.60 32.60 32.60
Nbr of stocks (in thousands) 333,250 395,710 405,450 384,180 381,284 384,818 384,818 -
Announcement Date 2/26/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (N) EV / Sales (N) EV / EBITDA (N) Yield (N) Capi.($)
-3.57x1.51x-1.39x-.--% 12.55B
51.93x7.07x25.13x0.74% 47.96B
28.36x3.19x13.33x-.--% 36.65B
89.62x11.23x40.43x0.27% 26.22B
22.21x2.25x10.75x-.--% 15.97B
14.12x4.64x8.92x-.--% 15.52B
61.41x9.32x26.88x0.44% 11.51B
29.6x5.08x23.25x-.--% 10.98B
54.33x4.64x12.56x-.--% 8.93B
Average 38.67x 5.44x 17.76x percentage-no-prefix 20.7B
Weighted average by Cap. 42.55x 5.81x 19.98x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. MRNA Stock
  4. Valuation Moderna, Inc.